Results of trabecular metal augments in Paprosky IIIA and IIIB defects: A multicentre study
Autor: | Krishna Kiran Eachempati, A K Podhili Subramani, S Pichai, Rajesh Malhotra, Neil P. Sheth, Deepak Gautam, V R Bollavaram, A V G Reddy |
---|---|
Rok vydání: | 2018 |
Předmět: |
Adult
Male Reoperation Arthroplasty Replacement Hip Treatment outcome Dentistry Prosthesis Design 03 medical and health sciences 0302 clinical medicine Prosthesis design Medicine Humans Orthopedics and Sports Medicine 030212 general & internal medicine Aged Retrospective Studies Aged 80 and over 030222 orthopedics business.industry Acetabular reconstruction Follow up studies Retrospective cohort study Acetabulum Middle Aged Prosthesis Failure Treatment Outcome Metals Surgery Female Hip Joint Hip Prosthesis Trabecular metal business Follow-Up Studies |
Zdroj: | The bonejoint journal. (7) |
ISSN: | 2049-4408 |
Popis: | Aims The advent of trabecular metal (TM) augments has revolutionized the management of severe bone defects during acetabular reconstruction. The purpose of this study was to evaluate patients undergoing revision total hip arthroplasty (THA) with the use of TM augments for reconstruction of Paprosky IIIA and IIIB defects. Patients and Methods A retrospective study was conducted at four centres between August 2008 and January 2015. Patients treated with TM augments and TM shell for a Paprosky grade IIIA or IIIB defect, in the absence of pelvic discontinuity, and who underwent revision hip arthroplasty with the use of TM augments were included in the study. A total of 41 patients with minimum follow-up of two years were included and evaluated using intention-to-treat analysis. Results There were 36 (87.8%) patients with a Paprosky IIIA defect and five (12.2%) patients with a Paprosky IIIB defect. The mean age was 56.7 years (28 to 94). There were 21 (51.2%) women and 20 (48.8%) men. The mean follow-up was 39.4 months (12 to 96). One (2%) patient died after eight years. No failures were noted in the series. The mean survivorship was 100% at the time of latest follow-up. Conclusion The results of this multicentre study showed encouraging short- and mid-term results for the use of TM augments in the management of Paprosky grade IIIA and IIIB defects. Cite this article: Bone Joint J 2018;100-B:903–8. |
Databáze: | OpenAIRE |
Externí odkaz: |